These findings not only support the notion that initial tumor control is independent of lymphocytes (see also Fig. 2), but also indicate that the CD8+ T cells accumulating in BP tumors in response to LTX-315 treatment have antitumor functions and are involved in suppressing cancer progression during the following weeks. This evidence concerns the gene CD8A and cancer.